Replies to post #226285 on Biotech Values

[DewDiligence]

ENTA’s CEO exercised-and-held $410K of stock today:

https://www.sec.gov/Archives/edgar/data/1177648/000117764819000035/xslF345X03/edgar.xml

The exercised options did not expire until Dec 2022.

The above transaction is in addition to the almost $1million of open-market buys by ENTA’s General Counsel during 2019 (#msg-151441695).

[DewDiligence]

ENTA’s General Counsel exercised and held ~$100K of stock on 11/22/19:

https://www.sec.gov/Archives/edgar/data/1177648/000117764819000042/xslF345X03/edgar.xml

The options in question did not expire until 2025.

The above transaction is in addition to: the $300K exercise-and-hold in Sep 2019 (#msg- 151441695); the $270K exercise-and-hold in Jun 2019 (#msg-149617660); the $250K exercise-and-hold in Mar 2019 (#msg-147373277); and the $150K exercise-and-hold in Jan 2019 (#msg-146329304).

All told, that comes to $1.1M of cumulative exercise-and-hold transactions during 2019 by this ENTA executive officer.

Separately, ENTA’s CEO exercised-and-held $410K of stock in Oct 2019 (#msg-151617214).

Plainly, ENTA insiders are bullish.